David Alan Campbell Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 months ago
David Alan Campbell has an estimated net worth of at least $14.9 million*, as of Oct. 29, 2025. They own 381,582 shares of JANX stock. They have sold 128,072 shares of JANX stock since 2021, for an estimated $6.5 million.
David Alan Campbell $JANX SEC Form 4 Insider Trading
David Alan Campbell has filed a total of 11 insider trades in $JANX since 2021. Their most recent trade was a sale of 8,072 shares, made on Jan 02, 2026. Their largest trade was a sale of 25,000 shares, made on Dec 24, 2024. We estimate that they now own 381,582 shares of $JANX, worth an estimated $8.4 million.
Insider Trading at $JANX
There have been a total of 120 insider trades reported at $JANX since 2021, with 11.4 million shares purchased and 7.9 million shares sold. The most active insider traders in $JANX stock have been Andrew Hollman Meyer, David Alan Campbell, and Tighe Reardon. The most recent trade was a sale of 1,879 shares reported by Andrew Hollman Meyer (Chief Business Officer), made on Jan 02, 2026.
History of Insider Stock Trades by David Alan Campbell
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
JANX
|
Sale | 8,072 | Jan 02, 2026 | Jan. 2, 2026, 10 p.m. |
|
JANX
|
Sale | 5,000 | Jan 07, 2025 | Jan. 8, 2025, 9 p.m. |
|
JANX
|
Sale | 25,000 | Dec 24, 2024 | Dec. 27, 2024, 9 p.m. |
|
JANX
|
Sale | 15,000 | Dec 03, 2024 | Dec. 3, 2024, 9 p.m. |
|
JANX
|
Sale | 18,281 | Nov 25, 2024 | Nov. 27, 2024, 9 p.m. |
|
JANX
|
Sale | 6,719 | Nov 25, 2024 | Nov. 27, 2024, 9 p.m. |
|
JANX
|
Sale | 11,103 | Oct 28, 2024 | Oct. 30, 2024, 7:30 p.m. |
|
JANX
|
Sale | 13,897 | Oct 28, 2024 | Oct. 30, 2024, 7:30 p.m. |
|
JANX
|
Sale | 18,957 | Sep 27, 2024 | Sept. 27, 2024, 7:30 p.m. |
|
JANX
|
Sale | 795 | Sep 27, 2024 | Sept. 27, 2024, 7:30 p.m. |
|
JANX
|
Sale | 5,248 | Sep 27, 2024 | Sept. 27, 2024, 7:30 p.m. |
$JANX Executives and Stock Owners with Insider Trades
-
Andrew Hollman Meyer, Chief Business Officer
-
David Alan Campbell, President and CEO
-
Tighe Reardon, Acting Chief Financial Officer
-
Thomas Diraimondo, Chief Scientific Officer
-
Charles M. Winter, Chief Technical Officer
-
Maria Dobek, Vice President, Accounting
-
Zachariah Mciver, Chief Medical Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.